About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Seattle | 11,373 Studies Near You

Clinical TrialsSeattle

Clinical Trials in Seattle

Discover 11,373 clinical trials near Seattle, Washington. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 5241-5260 of 11,373 trials

CompletedA Multicenter, Randomized, Parallel Group, Double-Blind, Placebo Controlled, Flexible Dose Escalation Study To Evaluate Sexual And Relationship Satisfaction In The Female Partner Of Men With Erectile Dysfunction Treated With Sildenafil CitrateTo compare the effects of sildenafil versus placebo on the female partner's sexual satisfaction as assessed by Question 3 of Female Partner of Erectile Dysfunction (ED) Subject…NCT00644631·Huntsville, Alabama and 30 others

Find Trials by Condition in Seattle

Breast Cancerin Seattle Lung Cancerin Seattle Prostate Cancerin Seattle Colorectal Cancerin Seattle Melanomain Seattle Leukemiain Seattle Lymphomain Seattle Pancreatic Cancerin Seattle Ovarian Cancerin Seattle Brain Cancerin Seattle Diabetes

Data from ClinicalTrials.govTerms

RecruitingA Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic CancerThis study will assess the safety and efficacy of VS-7375 alone and in combination with cetuximab in patients with metastatic KRAS G12D - mutated Pancreatic CancerNCT07644559·Los Angeles, California and 30 others

CompletedA Tolerability Study of ALKS 8700 in Subjects With Relapsing Remitting Multiple Sclerosis (RRMS) EVOLVE-MS-2The objectives of this study are to evaluate the utility of two gastrointestinal (GI) symptom scales (Individual GI Symptom and Impact Scale {IGISIS} and Global GI Symptom and…NCT03093324·Cullman, Alabama and 66 others

CompletedGemcitabine in Treating Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous LeukemiaRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00006462·Birmingham, Alabama and 224 others

CompletedRetrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United StatesThe Opsumit Users registry (OPUS; NCT02126943) was developed to characterize the safety profile of Opsumit and to describe clinical characteristics and outcomes of patients newly…NCT03197688·Phoenix, Arizona and 105 others

RecruitingA Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System LymphomaThe purpose of this study is to evaluate the safety and efficacy of lisocabtagene maraleucel (Breyanzi/liso-cel/BMS-986387) in adults as first-line treatment in…NCT07015242·Aurora, Colorado and 39 others

CompletedA Study of Duloxetine in Major Depressive Disorder (MDD) and Associated Painful SymptomsThe purpose of this study is to find out if 60 mg of duloxetine given once a day by mouth for 8 weeks to patients diagnosed with major depressive disorder, who also report…NCT01000805·Beverly Hills, California and 36 others

TerminatedA Study to Determine the Effectiveness of Endoscopic Full-Thickness Plication for the Treatment of GERDThe aim of this study was to determine the effectiveness of endoscopic full-thickness plication (Plicator; NDO Surgical, Inc., Mansfield, MA) for the treatment of GERD in…NCT00575822·Orange, California and 14 others

CompletedPharmacokinetic and Pharmacodynamic Study of Emixustat in Subjects With Geographic Atrophy Associated With Dry Age-Related Macular DegenerationThe purpose of this study is to characterize emixustat hydrochloride pharmacokinetic and pharmacodynamic parameters in subjects with geographic atrophy associated with dry…NCT02130531·Seattle, Washington

CompletedA Double-Blind Placebo-Controlled Trial of the Safety and Immunogenicity of a Seven Valent Pneumococcal Conjugate Vaccine in Presumed HIV-Infected InfantsTo assess whether HIV-infected infants who receive a heptavalent pneumococcal conjugate vaccine have more local reactions at the site of injection and systemic reactions than…NCT00000829·Los Angeles, California and 32 others

CompletedCMA-676 in Treating Patients With Acute Myeloid Leukemia in First RelapseRATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die.NCT00003131·Tucson, Arizona and 12 others

CompletedA Study of ZN-c5 in Subjects With Breast CancerThis is a Phase 1/2, open-label, multicenter, dose-escalation and expansion study to evaluate the safety, tolerability, pharmacokinetics, and preliminary efficacy of ZN-c5…NCT03560531·Tucson, Arizona and 37 others

CompletedEvaluating the Relationship Between Fatty Acids and Heart DiseaseCardiovascular disease (CVD) affects millions of people in the United States; each year, more people die from CVD than from any other disease.NCT00404872·Boston, Massachusetts and 3 others

CompletedOnvansertib in Combination With Either Low-dose Cytarabine or Decitabine in Adult Patients With Acute Myeloid Leukemia (AML)The purpose of the phase 1b/2 study is to determine whether Onvansertib given orally daily for 5 consecutive days every 28 days is safe and tolerable in adult patients who have…NCT03303339·Los Angeles, California and 8 others

Active not recruitingA Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Kidney Transplants Who Have Antibody-Mediated Rejection (AMR)In this study, researchers will learn more about the use of felzartamab in kidney transplant patients who have antibody-mediated rejection, also known as AMR.NCT06685757·Los Angeles, California and 55 others

CompletedImproving Firearm Storage in Alaska Native VillagesRates of suicide among young Alaska Native males are over ten-fold higher than among a similar age cohort in the rest of the United States.NCT00643812·Seattle, Washington

CompletedBrentuximab Vedotin and Combination Chemotherapy in Treating Patients With Stage II-IV HIV-Associated Hodgkin LymphomaThis pilot phase I/II trial studies the side effects and the best dose of brentuximab vedotin when given together with combination chemotherapy and to see how well they work in…NCT01771107·La Jolla, California and 27 others

CompletedYttrium Y 90 Ibritumomab Tiuxetan, Fludarabine, Radiation Therapy, and Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaMonoclonal antibodies, such as yttrium Y 90 ibritumomab tiuxetan, can block find cancer cells and either kill them or carry cancer-killing substances to them without harming…NCT00119392·Seattle, Washington

CompletedPrenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child TransmissionThe purpose of this study is to collect and study clinical and laboratory information about a pregnant or new mother and her medical care that will increase our knowledge of the…NCT00028145·Birmingham, Alabama and 76 others

CompletedValidation of Diagnostics to Identify Glucose-6-phosphate Dehydrogenase Activity in the USThe primary objective of this study is to assess the accuracy of the SD Biosensor STANDARD G6PD Analyzer in measuring G6PD activity when used by trained health care workers.NCT04010695·Seattle, Washington

PreviousPage 263 of 569Next

in Seattle

Heart Diseasein Seattle